We empower the World
We empower the World
Buscar
A future without pills – could AI change the way we treat psychiatric diseases?
Dr Cornelia Dorner-Ciossek talks about how her work with smartphone tech could transform how we treat mental illness.
Could decentralised trials transform the way we view depression?
Dr Vikas Mohan Sharma believes this new way of working could deliver meaningful changes for patients around the globe.
Boehringer Ingelheim: Discover the app set to transform animal care in rural India
The project will educate local communities on goat welfare, build trust and empower women.
Are combination therapies the answer to battling KRAS cancers?
Dr Ulrich Dünzinger and Kristie Fernamberg talk about their work with the SOS1 KRAS inhibitor to block tumour-triggering signals.
Moving to Germany
We started in Germany, but we have offices all over the world.
Empowering people services
Empowering people services
Empowering excellence
Empowering excellence
Empowering talent
Empowering talent
Empowering culture diversity
Empowering culture diversity
We nurture innovative ideas
Our Work
Discover your hidden talent with BI Open – the new platform for data science enthusiasts
The BI Open Data Science Challenge invites scientists to produce innovative solutions for untreatable conditions.
Boehringer Ingelheim: We support non-linear career paths
Emmanuelle Clerisme-Beaty talks about making breakthroughs in the rare disease space.
Mobile World Congress 2024
Mobile World Congress 2024
weBuy | English version
WeBuy: The New Source to Procure Solution for Boehringer Ingelheim based on SAP Ariba®.
FRONTLINE® galardonada como Marca Global del Año 2021-2022 en los World Branding Awards
FRONTLINE® galardonada como Marca Global del Año 2021-2022 en los World Branding Awards.
Niha Agarwalla
Niha Agarwalla
Telemedicine – the standalone study that became the new normal
Dr Vijay Prabhakar tells us how a remote healing project made him a pandemic pioneer.
Clinical trials deliver medical breakthroughs – but how do they happen?
Prof. Dr Martina Brueckmann talks about her role getting new drugs to trial.
Leadership
Leadership
Innovation from within
Justine Rochon and Marc Weimer talk about the transformation of Biostatistics and Data Sciences (BDS) into a modern organisation in drug development.
Interview with Gerhard Kraus
Interview with Gerhard Kraus
Más que esclerodermia
Más que esclerodermia
Interview with Michael Schmelmer
Interview with Michael Schmelmer
Boehringer Ingelheim y OSE Immunotherapeutics amplían su colaboración para desarrollar tratamientos de primera clase para cáncer y enfermedades cardio, renal y metabólicas
Nota de prensa Pipeline Boehringer en oncología y enfermedades cardio, renal y metabólicas